EJC Supplements

Published by: Pergamon-Elsevier Science Ltd  

People

  1. Aghajanian
    Aghajanian
  2. Lichtman
    Lichtman
  3. Bach
    Bach
  4. Hamlin
    Hamlin
  5. Hudis
    Hudis
  6. Sabbatini
    Sabbatini
  7. Seidman
    Seidman
  8. Sugarman
    Sugarman
  9. Troso-Sandoval
    Troso-Sandoval

Groups

  1. Department of Medicine (6)
  2. Gynecologic Medicine Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GDMT, Medicine (4)
  5. Gynecology Disease Management Team (4)
  6. Body Imaging Service (1)
  7. Breast Medicine Service (1)
  8. Center for Hematologic Malignancies (1)
  9. Hematologic Malignancies, Division of (1)
  10. Lymphoma (1)
Search Within
  1. "Gynecologic Medicine Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Department of Medicine (6)
  2. Gynecologic Medicine Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GDMT, Medicine (4)
  5. Gynecology Disease Management Team (4)
  6. Body Imaging Service (1)

More Groups

People
  1. Carol Aghajanian (2)
  2. Stuart Lichtman (2)
  3. Alison Conlin (1)
  4. Andrew Seidman (1)
  5. Ariadne Bach (1)
  6. Clifford Hudis (1)

More People

Years
  1. 2008 (2)
  2. 2007 (2)
  3. 2005 (1)
  4. 2004 (1)
Publishers
  1. Pergamon-Elsevier Science Ltd (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nanoparticle albumin-bound paclitaxel in 3 dosing schedules with bevacizumab as first line therapy for HER2-negative metastatic breast cancer: An interim safety analysis
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Moynahan, M. E.; Bach, A.; Troso-Sandoval, T.; Sugarman, S.; Forero, A.; Kerr, R.; Wright, G.; Hudis, C. A.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • NPI-0052 (a 2nd generation proteasome inhibitor) Phase 1 study in patients with lymphoma and solid tumors
    Meeting Abstract

    Kurzrock, R.; Hamlin, P.; Gordon, M.; Hong, D.; Fu, S.; Younes, A.; Hannah, A.; Palladino, M. A.; Spear, M. A.; Aghajanian, C.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Chemotherapy in elderly patients with renal insufficiency. Recommendations of the International Society of Geriatric Oncology (SIOG)
    Meeting Abstract

    Lichtman, S. M.; Wildiers, H.; Launay-Vacher, V.; Steer, C.; Chatelut, E.; Aapro, M.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology (SIOG) clinical practice recommendations
    Meeting Abstract

    Launay-Vacher, V.; Chatelut, E.; Lichtman, S. M.; Wildiers, H.; Steer, C.; Aapro, M.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Clinical activity of single agent pertuzumab (rhuMab 2C4), a HER dimerization inhibitor, in advanced ovarian cancer (OC): Potential predictive relationship with tumor HER2 activation status
    Meeting Abstract

    Gordon, M. S.; Matel, D.; Aghajanian, C.; Matulonis, U.; Brewer, M.; Fleming, G.; Hainsworth, J.; Garcia, A. A.; Pegram, M.; Karlan, B.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Strategies for optimizing hemoglobin response in cancer patients: Focus on new epoetin alfa dosing regimens
    Journal Article

    Sabbatini, P.
    EJC Supplements (2004)

    Fulltext@MSK | Save

    • EJC Supplements – authorized name for:

    Name ISSN / ISBN Publisher
    EJC Supplements 1359-6349 Pergamon-Elsevier Science Ltd
    EJC Supplements 1359-6349 Unknown
    European Journal of Cancer Supplements 1359-6349 Elsevier Inc.
    European Journal of Cancer Supplements 1359-6349 Elsevier Inc.
    European Journal of Cancer Supplements 1359-6349 Pergamon-Elsevier Science Ltd
    European Journal of Cancer, Supplement 13596349 Elsevier Inc.
    European Journal of Cancer, Supplement 13596349 Unknown